Dr Kumeren Govender, M.D., DPhil, is a physician, academic, and entrepreneur with extensive expertise in global health, medicine, and biotechnology. He served as the Chief Scientific Officer at the Ellison Institute of Technology, where he led strategic initiatives in pandemic preparedness and global health innovation, partnering with institutions such as Oxford University. Previously, Kumeren held leadership roles at the Global Pathogen Analysis Service and co-founded Neurolytic Healthcare, a precision medicine start-up raising over $3 million. A Rhodes Scholar, he earned a DPhil in Clinical Medicine at Oxford, specialising in metagenomic sequencing for clinical diagnostics. Kumeren’s accolades include the Oxford Vice-Chancellor’s Innovation Award, a Y-Combinator start-up fellowship, and recognition as one of South Africa’s Top 200 Young Achievers. He has authored numerous academic publications, and remains active in policy roles, including work with OpenAI on medical AI models.